
NanoFCM
NanoFCM and its leading-edge technology, the NanoAnalyzer, provide a comprehensive solution for high fidelity analysis of thousands of individual EVs. This specialized nano-flow cytometry platform performs label-free measurement of >45nm particles, generating a concentration and size distribution profile with simultaneous sub-population analysis acquired through versatile fluorescent labelling of targets. With the NanoAnalyzer, quantify the proportion of EVs with a given biomarker, an identifier of cell/tissue origin, or those EVs which carry your specific cargo.

Rooster Bio
RoosterBio accelerates human mesenchymal stem cell and exosome product and process development to fuel the rapid implementation of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing under GMP at lower cost and higher productivity. RoosterBio is driven by client success to create a world where safe, effective advanced therapies are rapidly developed on a global scale.